Boai NKY Pharmaceuticals Ltd Strategic Asset Allocation Index
Boai NKY Pharmaceuticals Ltd strategic asset allocation index. Boai NKY Pharmaceuticals Ltd (300109) has a Strategic Asset Allocation Index of 28.6% as of June 2023. Strategic assets (PP&E of CN¥926.45 Million plus long-term investments of CN¥-) total CN¥926.45 Million, measured against net assets of CN¥3.24 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Boai NKY Pharmaceuticals Ltd (300109) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Boai NKY Pharmaceuticals Ltd (2007–2022)
Strategic asset allocation index of Boai NKY Pharmaceuticals Ltd from 2007 to 2022. This chart shows how Boai NKY Pharmaceuticals Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of June 2023, the index stands at 28.6%, representing strategic assets of CN¥926.45 Million against net assets of CN¥3.24 Billion CNY. Check 300109 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Boai NKY Pharmaceuticals Ltd Strategic Asset Allocation Index by Year (2007–2022)
Boai NKY Pharmaceuticals Ltd strategic asset allocation index by year from 2007 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Boai NKY Pharmaceuticals Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Boai NKY Pharmaceuticals Ltd (300109) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.1% | CN¥844.80 Million | CN¥844.80 Million | CN¥- | CN¥3.12 Billion | ▲ +5.6 pp |
| 2021 | 21.5% | CN¥731.25 Million | CN¥731.25 Million | CN¥- | CN¥3.40 Billion | ▲ +1.6 pp |
| 2020 | 19.9% | CN¥610.95 Million | CN¥610.95 Million | CN¥- | CN¥3.08 Billion | ▲ +1.2 pp |
| 2019 | 18.7% | CN¥569.55 Million | CN¥569.55 Million | CN¥- | CN¥3.05 Billion | ▼ -20.8 pp |
| 2018 | 39.5% | CN¥503.91 Million | CN¥503.91 Million | CN¥- | CN¥1.28 Billion | ▲ +5.3 pp |
| 2017 | 34.2% | CN¥445.61 Million | CN¥445.61 Million | CN¥- | CN¥1.30 Billion | ▲ +4.8 pp |
| 2016 | 29.4% | CN¥360.22 Million | CN¥360.22 Million | CN¥- | CN¥1.23 Billion | ▲ +0.2 pp |
| 2015 | 29.1% | CN¥338.64 Million | CN¥338.64 Million | CN¥- | CN¥1.16 Billion | ▼ -44.1 pp |
| 2014 | 73.2% | CN¥292.89 Million | CN¥292.89 Million | CN¥- | CN¥400.25 Million | ▼ -3.4 pp |
| 2013 | 76.6% | CN¥288.77 Million | CN¥288.77 Million | CN¥- | CN¥377.06 Million | ▲ +5.7 pp |
| 2012 | 70.8% | CN¥257.74 Million | CN¥257.74 Million | CN¥- | CN¥363.81 Million | ▲ +21.8 pp |
| 2011 | 49.0% | CN¥171.97 Million | CN¥171.97 Million | CN¥- | CN¥350.93 Million | ▲ +29.7 pp |
| 2010 | 19.3% | CN¥64.29 Million | CN¥64.29 Million | CN¥- | CN¥333.21 Million | ▼ -32.0 pp |
| 2009 | 51.2% | CN¥31.84 Million | CN¥31.84 Million | CN¥- | CN¥62.14 Million | ▲ +1.8 pp |
| 2008 | 49.4% | CN¥21.71 Million | CN¥21.71 Million | CN¥- | CN¥43.93 Million | ▼ -38.3 pp |
| 2007 | 87.7% | CN¥15.63 Million | CN¥15.63 Million | CN¥- | CN¥17.82 Million | — |